Narayana Hrudayalaya Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for NH, BSE:539551 Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd.

12 Aug 2019

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Recommendation

ICICI Securities Limited

Blended model of affordable + high-quality services The company has a legacy model based on affordability over the years. Due to strict control over costs and capital, the company was making reasonable profit. However, as it looks to scale up in other regions, where the consideration for quality has more weight than affordability, the model is likely to be modified from 'affordable'' to a mix of affordable + quality at premium. Cases in point are the recent acquisition of Gurugram Hospital and buying out of partner in the Cayman Islands hospital internationally where...

Narayana Hrudayalaya Ltd. has gained 44.04% in the last 1 Year

Narayana Hrudayalaya Ltd.

28 May 2019

1759.00

-0.62%

Narayana Hrudayalaya

Hold: Narayana Hrudayalaya Ltd.

Recommendation Target

ICICI Securities Limited

Blended model of affordable + high-quality services The company has a legacy model based on affordability over the years. Due to strict control over costs and capital, NHL was making reasonable profits. However, as it looks to scale up in other regions, where the consideration for quality has more weight than affordability, the model is likely to be modified from 'affordable'' to a mix of affordable + quality at premium. Cases in point are the recent acquisition of Gurugram Hospital and buying out of partner in the Cayman Islands hospital internationally where...

Narayana Hrudayalaya Ltd. is trading below its 30 day SMA of 1767.1

Narayana Hrudayalaya Ltd.

06 Feb 2019

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Securities Limited

Q3FY19 results were a mixed bag with revenues and EBITDA above I-direct estimates while net profit was lower than I-direct estimates due to higher depreciation and tax rate Revenues grew 32.2% YoY to | 732 crore (I-direct estimate: | 713 crore) mainly due to consolidation of Health City Cayman Islands (Cayman)and ramp up in new hospitals EBITDA margins improved 136 bps YoY to 10.6% (I-direct estimate: 10.1%) mainly due to lower other expenditure. EBITDA grew 51.5%...

Narayana Hrudayalaya Ltd. is trading below its 30 day SMA of 1767.1

Narayana Hrudayalaya Ltd.

02 Nov 2018

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Securities Limited

Narayana Hrudayalaya's Q2FY19 results were operationally better than I-direct estimates. Revenues grew 27.2% YoY to | 711.3 crore (Idirect estimate: | 696.8 crore) mainly due to consolidation of Health City Cayman Islands Ltd (Cayman) EBITDA margins declined 74 bps YoY to 10.3% (I-direct estimate: 7.4%) mainly due to higher employee expenses. EBITDA grew 21.6% YoY to | 73.0 crore (I-direct estimate: | 51.8 crore) Net profit declined 20.6% YoY to | 13.6 crore (I-direct estimate: | 5.4 crore) due to strong operational performance...

Narayana Hrudayalaya Ltd. is trading below its 30 day SMA of 1767.1

Narayana Hrudayalaya Ltd.

07 Aug 2018

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 25.2% YoY to | 652.3 crore (I-direct estimate: | 609.4 crore) mainly due to consolidation of Health City Cayman Islands Ltd (Cayman) and incremental revenues from new hospitals EBITDA margins declined 240 bps YoY to 7.3% (I-direct estimate: 8.3%) mainly due to higher employee expenses. EBITDA de-grew 5.9% YoY to | 47.4 crore (I-direct estimate: | 50.4 crore) Net loss was at | 4.1 crore (I-direct estimate of net profit: | 5.8 crore)...

Narayana Hrudayalaya Ltd. is trading below its 30 day SMA of 1767.1

Narayana Hrudayalaya Ltd.

31 May 2018

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 34% YoY to | 647 crore (I-direct estimate: | 595 crore) mainly due to consolidation of Health City Cayman Islands (Cayman) and incremental revenues from new hospitals EBITDA margins declined 398 bps YoY to 8.1% (I-direct estimate: 12.0%) mainly due to an increase in doctor payouts, expenses related to new facilities, GST implementation besides losses related to stent and implants regulation. EBITDA de-grew 10.3% YoY to | 52...

Narayana Hrudayalaya Ltd. is trading above its 200 day SMA of 1691.0

Narayana Hrudayalaya Ltd.

07 Feb 2018

1759.00

-0.62%

Result Update:Narayana Hrudaya

Buy: Narayana Hrudayalaya Ltd.

Target

Axis Direct

Q3 revenue was up 22% YoY on strong volume growth, but EBITDA slipped 2% YoY on (1) EBITDA loss of ~Rs 70 mn at its recently-commissioned children's hospital in Mumbai and (2) investments on talent acquisition especially at its new hospitals.

Narayana Hrudayalaya Ltd. has gained 44.04% in the last 1 Year

Narayana Hrudayalaya Ltd.

05 Feb 2018

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

ICICI Securities Limited

Revenues grew 22% YoY to | 554 crore mainly due to an improvement in ARPOB and occupancy rates. However, revenues were below I-direct estimate of | 587 crore mainly due to lower-thanexpected ARPOB (80 lakh vs. I-direct estimate of 84.8 lakh) and lower...

Narayana Hrudayalaya.. has an average target of 1781.75 from 4 brokers.

Narayana Hrudayalaya Ltd.

26 Dec 2017

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

Target

ICICI Securities Limited

Blended model of affordable + high-quality services Narayana Hrudayalaya (NHL) has a legacy model based on affordability over the years. Due to strict control over costs and capital, the company was making reasonable profits. However, as it looks to scale up in other regions, where the consideration for quality has more weight than affordability, the model is likely to be modified from 'affordable'' to a mix of affordable + quality at premium. Cases in point are the recent acquisition of Gurugram hospital and buying out of partner in the Cayman...

Narayana Hrudayalaya Ltd. is trading above its 200 day SMA of 1691.0

Narayana Hrudayalaya Ltd.

08 Dec 2017

1759.00

-0.62%

Narayana Hrudayalaya

Buy: Narayana Hrudayalaya Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research We met the management of Narayana Hrudayalaya (NHL) to understand its business model and future prospects. NHL was founded by cardiac surgeon Dr Devi Prasad Shetty in 2000. The company operates as a chain of multispecialty, tertiary and primary healthcare facilities. NHL has a strong legacy in cardiac and renal sciences. Cardiac sciences alone contributed 42% to FY17 sales. The company has a strong presence in Karnataka and Eastern India. NHL is also growing in western and central India. The...

Narayana Hrudayalaya Ltd. is trading above its 200 day SMA of 1691.0

Is Narayana Hrudayalaya Ltd. worth buying?

217 Votes:

Buy 80.18%

Sell 15.21%

Hold 4.61%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf